Annual Drug Patent Expirations for LOTEMAX+SM
Lotemax Sm is a drug marketed by Bausch And Lomb Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
Drug patent litigation for LOTEMAX SM.
This drug has eighteen patent family members in thirteen countries.
The generic ingredient in LOTEMAX SM is loteprednol etabonate. One supplier is listed for this compound. Additional details are available on the loteprednol etabonate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com